至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Engineering galactose oxidase for biocatalytic synthesis of 2-(furan-2-yl)-2-oxoacetic acid, a critical precursor of cefuroxime

Journal Pre-proof. 2025-05; 
Tong Zhang, Hao Wei, Yunju Zhang, Tengteng Qi, Kehao Yuan, Bin Wang, Ziyan Zhang, Liangqing Chen, Qinyuan Ma, Xiuzhen Gao
Products/Services Used Details Operation

摘要

2-(Furan-2-yl)-2-oxoacetic acid (2-FOA) is a critical building block for the C7 side chain of cefuroxime, a second-generation antibiotic. Traditional chemical synthesis of 2-FOA involves harsh conditions and toxic reagents, creating significant environmental challenges. Here, we developed an alternative biocatalytic approach to produce 2-FOA, beginning with the condensation of furfural and formaldehyde to form 2-furyl hydroxymethyl ketone (2-FHMK), followed by enzymatic oxidation to 2-FOA. To address the rate-limiting oxidation step, we engineered a galactose oxidase from Fusarium graminearum (FgGOase) through error-prone PCR and site-saturation mutagenesis. The optimal variant M13 exhibited 46-fold and 102-fol... More

关键词